Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Salt Lake City, Utah 84148


Purpose:

The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.


Criteria:

Inclusion Criteria: - Male VA bilateral TKA patients 18 years or older with primary OA diagnosis Exclusion Criteria: - Patients with osteoporosis, hypersensitivity to Celebrex, allergy to tetracycline, Sulfonamides, patient with asthma, urticaria, or allergic-type reactions to aspirin or NSAIDs. - Patients who have had CABG. - Patients with a history of peptic ulcer disease, duodenal ulcers. - Female patients and patients diagnosed with unstable hypertension or hypotensive, with serum creative levels above 1.8-2.0 or diagnosed with severe renal disease.


NCT ID:

NCT00585156


Primary Contact:

Principal Investigator
Roy Bloebaum, Ph.D.
Research Professor, Orthopedic Surgery


Backup Contact:

N/A


Location Contact:

Salt Lake City, Utah 84148
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.